2025 Annual Meeting | C85 - Clinical Approach to Sleep Disorders

Date Monday 04/07/25

Time 07:00 AM - 09:00 AM PDT Add To Calendar

Location San Diego Convention Center | 4

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Rachel Marie E. Salas, MD, MEd, FAAN

Topic(s) Sleep

Learning Objectives Participants should be able to describe the clinical presentation, diagnostic criteria, and evolving understanding of sleep disorders, including OSA, narcolepsy, insomnia, RLS, and RBD, with a focus on recent advancements in pathophysiology and diagnostic tools.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Audience Participation

Program Materials Program Evaluations

Event Timeline
07:05 AM - 07:05 AM PDT	Introduction	Introduction Rachel Marie E. Salas, MD, MEd, FAAN
07:05 AM - 07:40 AM PDT	Speaker	General Approach to Sleep Disorders and Insomnia Rachel Marie E. Salas, MD, MEd, FAAN
07:40 AM - 08:15 AM PDT	Speaker	OSA and Narcolepsy J. Kent Werner, Jr., MD, PhD
08:15 AM - 08:50 AM PDT	Speaker	Restless Legs Syndrome (RLS) and REM Sleep Behavior Disorder (RBD) Ambra Stefani, MD, PhD
08:50 AM - 09:00 AM PDT	Q&A	Questions and Answers Rachel Marie E. Salas, MD, MEd, FAAN

Faculty Disclosures
Rachel Marie E. Salas, MD, MEd, FAAN	Dr. Salas has received personal compensation for serving as an employee of ScholarRx. Dr. Salas has received personal compensation for serving as an employee of HMPGlobal. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Learning Network. Dr. Salas has received publishing royalties from a publication relating to health care.
J. Kent Werner, Jr., MD, PhD	Dr. Werner has received personal compensation for serving as an employee of Cogentis Therapeutics. Dr. Werner has stock in Cogentis Therapeutics. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with United States Navy. Dr. Werner has received personal compensation in the range of $50,000-$99,999 for serving as a CEO / CoFounder with Cogentis Therapeutics.
Ambra Stefani, MD, PhD	Dr. Stefani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurim. Dr. Stefani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Stefani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Idorsia. Dr. Stefani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Stefani has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. Dr. Stefani has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain Sciences. The institution of Dr. Stefani has received research support from Dr. Johannes und Hertha Tuba Foundation Research Funding. Dr. Stefani has received research support from Max-Kade Fellowship . The institution of Dr. Stefani has received research support from Tyrolean Research Fund 2021. Dr. Stefani has received publishing royalties from a publication relating to health care.

��ɫ��

��ɫ��